WallStreetZenWallStreetZen

NASDAQ: LRMR
Larimar Therapeutics Inc Stock Ownership - Who owns Larimar Therapeutics?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Larimar Therapeutics Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
James E. FlynnDirector2025-07-313,387,529$3.20
$10.84MBuy
James E. FlynnDirector2025-07-313,387,539$3.20
$10.84MBuy
James E. FlynnDirector2025-07-312,599,932$3.20
$8.32MBuy

1 of 1

LRMR insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when LRMR insiders and whales buy or sell their stock.

LRMR Shareholders

What type of owners hold Larimar Therapeutics Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
James E. Flynn44.59%38,164,915$141.21MInsider
Deerfield Management Company LP35.76%30,606,974$113.25MInstitution
Peter Barrett12.01%10,276,057$38.02MInsider
Bruce Booth12.00%10,270,758$38.00MInsider
Ra Capital Management LP7.06%6,045,351$22.37MInstitution
Blue Owl Capital Holdings LP6.84%5,853,040$21.66MInstitution
Millennium Management LLC5.72%4,896,831$18.12MInstitution
Opaleye Management Inc4.35%3,720,867$13.77MInstitution
Blackrock Inc3.90%3,339,192$12.36MInstitution
Rtw Investments LP3.65%3,125,000$11.56MInstitution

1 of 3

LRMR vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
LRMR57.15%42.85%Net Buying
AVTX15.86%84.14%Net SellingNet Selling
VNDA52.44%47.56%Net Selling
NGNE46.19%53.81%Net Selling
ALLO67.48%32.52%Net SellingNet Selling
View Top Biotech Stocks

Larimar Therapeutics Stock Ownership FAQ

Who owns Larimar Therapeutics?

Larimar Therapeutics (NASDAQ: LRMR) is owned by 99.91% institutional shareholders, 74.91% Larimar Therapeutics insiders, and 0.00% retail investors. James E. Flynn is the largest individual Larimar Therapeutics shareholder, owning 38.16M shares representing 44.59% of the company. James E. Flynn's Larimar Therapeutics shares are currently valued at $141.21M.

If you're new to stock investing, here's how to buy Larimar Therapeutics stock.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.